SCHEMBL4846291

SCHEMBL4846291

COCOc1cc(C=O)ccc1OCc1nc(-c2ccco2)oc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.49
ALDH1A1 P00352 9/20 0.41
MAPT P10636 7/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
HSD17B10 Q99714 4/20 0.39
KDM4E B2RXH2 4/20 0.39
HPGD P15428 3/20 0.39
TSHR P16473 2/20 0.39
LMNA P02545 3/20 0.39
MAPK1 P28482 2/20 0.39
RAB9A P51151 2/20 0.39
NPSR1 Q6W5P4 2/20 0.38
ALOX15 P16050 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
USP2 O75604 2/20 0.38
GAA P10253 2/20 0.38
ANO1 Q5XXA6 1/20 0.38
PABPC1 P11940 1/20 0.38
POLB P06746 1/20 0.37
HTT P42858 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4848084 0.91 PPARG (0.53) PPARGALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL6160140 0.91 PPARG (0.57) PPARGALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL4852631 0.90 ALDH1A1 (0.49) PPARGALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL4850788 0.85 PPARG (0.47) PPARGALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL4851992 0.84 ALDH1A1 (0.47) PPARGALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL4845981 0.83 PPARG (0.53) PPARGALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL8335514 0.83 PPARG (0.55) PPARGALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL6584922 0.83 PPARG (0.55) PPARGALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL4029092 0.80 FFAR1 (0.45) PPARGALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL6966486 0.79 PPARG (0.53) PPARGALDH1A1MAPTSMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7368578-B2 Five-membered heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-06 US disclosed
US-20060135578-A1 Five-membered heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-06-22 US disclosed
EP-1541564-A1 FIVE-MEMBERED HETEROCYCLIC COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2005-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135578-A1 Five-membered heterocyclic compounds GPR119, OR10J3, CYP11B1 PPARG 536/4885ALDH1A1 821/4885MAPT 4700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.